During the past decade, Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "West German Study Group" with 3 trials sponsored, "University Hospital Tuebingen" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "AIO-Studien-gGmbH" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "Austrian Breast Cancer Study Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH" are "Breast Cancer" (4 trials), "Non-Small Cell Lung Cancer" (2 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Advanced/Metastatic Breast Cancer" (1 trials) and "Breast Cancer (Early Breast Cancer)" (1 trials). Many other conditions were trialed in "Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH" in a lesser frequency.

Most popular intervention types in "Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH" are "Drug" (18 trials), "Procedure" (3 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Atezolizumab" (3 trials), "Cisplatin" (2 trials), "Giredestrant" (2 trials) and "LHRH Agonist" (2 trials). Other intervention names were less common.

The vast majority of trials in "Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH" are 16 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Niels-Stensen-Kliniken Franziskus-Hospital Harderberg GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".